Access insight in the field of clinical and translational science, the latest research and ACTS news.
JCTS has received a new impact factor of 2.7 for 2025, an increase from their score of 2.0 in 2024. The number is based on the number of citations given in 2025 in relation to the number of citable publications in 2023 and 2024. The achievement is an indication of the rapid growth of the journal as well as of the high quality and broad interest in the articles published.
Read More Here
The Journal of Clinical and Translational Science (JCTS) is the official journal of the Association and is published through Cambridge University Press. JCTS accepts high-quality academic content in all areas of clinical and translational science research. Content includes:
JCTS is a natural forum to highlight advances in the translational science area. All content published is Gold Open Access and available for current members to view. Read the latest issue here and sign up with Cambridge Core to receive alerts when new issues are available.
Members can also share their critical contributions with the translational community by submitting manuscripts for review. JCTS is committed to responding to submitting authors in an expeditious fashion. For more information, including full journal scope, editorial policies and Gold Open Access fees, read the instructions for authors.
Benefits of publishing in JCTS:
Submit Your Research
If you have questions regarding current and/or previous submissions to the retired journal, CTS, please contact JCTS Editor-in-Chief Dr. Chris Lindsell or the JCTS Managing Editor Tracy Candelaria.